The Magnitude of Polypharmacy and Role of Disease Severity and Patient Sex in Medication Use Among Patients With MASLD Enrolled in TARGET ‐ NASH - Neuschwander‐Tetri, Brent A.; Morris, Heather L.; Mospan, Andrea R.; Yu, Feng; Munoz, Breda; Abraham, Sheenu; Fried, Michael W.; Barritt, A. Sidney; Al‐Sayyed, Leen; Sanyal, Arun J. (Alimentary pharmacology & therapeutics, 2025)
Keywords: NAFLD; mechanism of action; MASH; MASLD; NASH; cirrhosis; polypharmacy; steatotic liver disease